Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

NCT04411836 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

960

Enrollment

OTHER

Sponsor class

Conditions

Vivax Malaria
Plasmodium Vivax
Malaria, Vivax
Malaria Relapse

Interventions

DRUG: Tafenoquine
DRUG: Primaquine

Sponsor

Menzies School of Health Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]